+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Market by Route of Administration, Product Type, Technology, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Drug Delivery Market by Route of Administration, Product Type, Technology, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Sale

Drug Delivery Market by Route of Administration, Product Type, Technology, Therapeutic Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083895
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug delivery market is experiencing rapid transformation, driven by technological breakthroughs, changing regulatory landscapes, and evolving patient and provider preferences. Senior decision-makers must navigate these shifts to maintain agility, competitive advantage, and relevance as new opportunities and challenges emerge.

Market Snapshot: Drug Delivery Market

The Drug Delivery Market grew from USD 1.82 billion in 2024 to USD 1.94 billion in 2025. It is expected to continue growing at a CAGR of 6.46%, reaching USD 2.66 billion by 2030. This growth reflects demand from manufacturers, healthcare providers, and contract development organizations, as therapies become more sophisticated and patient-centric. Market expansion is fueled by innovation in advanced delivery systems, regulatory adjustments, and regional investments in healthcare infrastructure.

Scope & Segmentation

  • Route of Administration: Inhalation devices (dry powder inhalers, metered dose inhalers, nebulizers), injectables (auto injectors, infusion pumps, pen injectors, prefilled syringes, standard syringes), nasal delivery (powder, spray), ophthalmic solutions (drops, inserts), oral forms (capsules, oral films, tablets), and transdermal platforms (creams, gels, patches).
  • Product Type: Conventional devices, implantable pumps, microneedle patches, needle free injectors, and smart systems including connected and wearable injectors.
  • Technology: Hydrogel systems, lipid-based carriers, liposome carriers, microneedle technology, nanoemulsion systems, and polymer-based carriers.
  • Therapeutic Area: Cardiovascular disorders, CNS disorders, diabetes, oncology, pain management, and respiratory disorders.
  • End User: Ambulatory surgical centers, home healthcare, hospitals, and specialty clinics.
  • Regions Covered: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies Profiled: Johnson & Johnson, Becton Dickinson and Company, Baxter International Inc., Medtronic plc, 3M Company, Boston Scientific Corporation, B. Braun Melsungen AG, Abbott Laboratories, Fresenius Kabi AG, Sanofi S.A.

Key Takeaways for Senior Decision-Makers

  • Digital integration is transforming device functionality, with connected injectors and smart wearable systems enhancing adherence and providing actionable patient data for improved outcomes.
  • Regulatory shifts are accelerating market access, especially for combination products and minimally invasive therapies, streamlining approval for novel device technologies.
  • Sustainability considerations are prompting adoption of eco-friendly materials and refillable platforms, a priority for procurement and supply chain leaders responding to environmental mandates.
  • Partnerships between pharmaceutical firms and technology companies are driving innovation, reducing development timelines, and expanding market reach through targeted R&D collaborations.
  • Patient needs are increasingly driving product design, with ergonomic, user-friendly devices gaining traction across major regions and end-user settings.

Tariff Impact on the Drug Delivery Market

The upcoming U.S. tariff changes effective in 2025 are reshaping supply chains and increasing costs for imported equipment components and raw materials. As a result, manufacturers are investing in domestic production, implementing advanced automation, and renegotiating supplier agreements. This shift encourages risk mitigation through supply chain diversification, near-shoring, and the adoption of real-time tracking technologies to ensure resilience and continuity of care for patients.

Drug Delivery Market Analysis Methodology & Data Sources

Research is based on a blend of primary interviews with industry executives, regulatory specialists, clinicians, and procurement professionals, accompanied by secondary analysis of journals, regulatory filings, conference proceedings, and patent data. Quantitative modeling captures device use and technology trends, while qualitative insights highlight adoption barriers and partnership strategies. Data reliability is ensured through triangulation and strict verification procedures.

Why This Report Matters

  • Gain actionable intelligence for investment planning, risk mitigation, and operational strategy in a fast-evolving field.
  • Benchmark competitors and proactively adapt to changing technology, regulations, and competitive pressures influencing the global drug delivery market.

Conclusion

Understanding the landscape of the drug delivery sector enables organizations to respond confidently to evolving requirements. This report empowers teams with clarity to prioritize innovation, operational resilience, and long-term competitiveness within a rapidly advancing field.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Delivery Market, by Route of Administration
8.1. Introduction
8.2. Inhalation
8.2.1. Dry Powder Inhaler
8.2.2. Metered Dose Inhaler
8.2.3. Nebulizer
8.3. Injectable
8.3.1. Auto Injector
8.3.2. Infusion Pump
8.3.3. Pen Injector
8.3.4. Prefilled Syringe
8.3.5. Standard Syringe
8.4. Nasal
8.4.1. Powder
8.4.2. Spray
8.5. Ophthalmic
8.5.1. Drop
8.5.2. Insert
8.6. Oral
8.6.1. Capsule
8.6.2. Oral Film
8.6.3. Tablet
8.7. Transdermal
8.7.1. Cream
8.7.2. Gel
8.7.3. Patch
9. Drug Delivery Market, by Product Type
9.1. Introduction
9.2. Conventional Devices
9.3. Implantable Pumps
9.4. Microneedle Patches
9.5. Needle Free Injectors
9.6. Smart Systems
9.6.1. Connected Injector
9.6.2. Wearable Injector
10. Drug Delivery Market, by Technology
10.1. Introduction
10.2. Hydrogel System
10.3. Lipid Based Carrier
10.4. Liposome Carrier
10.5. Microneedle Technology
10.6. Nanoemulsion System
10.7. Polymer Based Carrier
11. Drug Delivery Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular Disorders
11.3. CNS Disorders
11.4. Diabetes
11.5. Oncology
11.6. Pain Management
11.7. Respiratory Disorders
12. Drug Delivery Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Center
12.3. Home Healthcare
12.4. Hospital
12.5. Specialty Clinic
13. Americas Drug Delivery Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Drug Delivery Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Drug Delivery Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Becton Dickinson and Company
16.3.3. Baxter International Inc.
16.3.4. Medtronic plc
16.3.5. 3M Company
16.3.6. Boston Scientific Corporation
16.3.7. B. Braun Melsungen AG
16.3.8. Abbott Laboratories
16.3.9. Fresenius Kabi AG
16.3.10. Sanofi S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DRUG DELIVERY MARKET MULTI-CURRENCY
FIGURE 2. DRUG DELIVERY MARKET MULTI-LANGUAGE
FIGURE 3. DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY PEN INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY STANDARD SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DELIVERY MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DELIVERY MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DELIVERY MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DELIVERY MARKET SIZE, BY DROP, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY MARKET SIZE, BY INSERT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DELIVERY MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DELIVERY MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DELIVERY MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DELIVERY MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DELIVERY MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DELIVERY MARKET SIZE, BY IMPLANTABLE PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG DELIVERY MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DELIVERY MARKET SIZE, BY NEEDLE FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONNECTED INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DELIVERY MARKET SIZE, BY HYDROGEL SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG DELIVERY MARKET SIZE, BY LIPID BASED CARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DELIVERY MARKET SIZE, BY LIPOSOME CARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG DELIVERY MARKET SIZE, BY MICRONEEDLE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DELIVERY MARKET SIZE, BY NANOEMULSION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG DELIVERY MARKET SIZE, BY POLYMER BASED CARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DELIVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DELIVERY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG DELIVERY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. CANADA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 94. CANADA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 95. CANADA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 96. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 97. CANADA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 98. CANADA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. CANADA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 100. CANADA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. CANADA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 102. CANADA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 107. MEXICO DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 108. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 109. MEXICO DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 110. MEXICO DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. GERMANY DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. GERMANY DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 166. GERMANY DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 167. GERMANY DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 168. GERMANY DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 169. GERMANY DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 170. GERMANY DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 171. GERMANY DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. GERMANY DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. GERMANY DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. GERMANY DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 175. GERMANY DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 178. FRANCE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 180. FRANCE DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 181. FRANCE DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 182. FRANCE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 183. FRANCE DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. FRANCE DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. FRANCE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 187. FRANCE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ITALY DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. ITALY DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 202. ITALY DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 203. ITALY DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 204. ITALY DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 205. ITALY DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 206. ITALY DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 207. ITALY DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. ITALY DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. ITALY DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. ITALY DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 211. ITALY DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SPAIN DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 214. SPAIN DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 216. SPAIN DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 217. SPAIN DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 218. SPAIN DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 219. SPAIN DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SPAIN DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. SPAIN DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. SPAIN DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 223. SPAIN DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. DENMARK DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. DENMARK DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 262. DENMARK DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 263. DENMARK DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 264. DENMARK DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 265. DENMARK DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 266. DENMARK DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 267. DENMARK DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. DENMARK DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. DENMARK DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. DENMARK DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 271. DENMARK DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. QATAR DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. QATAR DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 286. QATAR DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 287. QATAR DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 288. QATAR DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 289. QATAR DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 290. QATAR DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 291. QATAR DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. QATAR DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 293. QATAR DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. QATAR DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 295. QATAR DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. FINLAND DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. FINLAND DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 298. FINLAND DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 299. FINLAND DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 300. FINLAND DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 301. FINLAND DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 302. FINLAND DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 303. FINLAND DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 305. FINLAND DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. FINLAND DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 307. FINLAND DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. SWEDEN DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 310. SWEDEN DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 311. SWEDEN DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 312. SWEDEN DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 313. SWEDEN DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 314. SWEDEN DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 315. SWEDEN DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. SWEDEN DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. NIGERIA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. NIGERIA DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 322. NIGERIA DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 323. NIGERIA DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 324. NIGERIA DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 325. NIGERIA DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 326. NIGERIA DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. EGYPT DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 333. EGYPT DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 334. EGYPT DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 335. EGYPT DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 336. EGYPT DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 337. EGYPT DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 338. EGYPT DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 339. EGYPT DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. EGYPT DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 341. EGYPT DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. EGYPT DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 343. EGYPT DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. TURKEY DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. TURKEY DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 346. TURKEY DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 347. TURKEY DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 348. TURKEY DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 349. TURKEY DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 350. TURKEY DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 351. TURKEY DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 352. TURKEY DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 353. TURKEY DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 354. TURKEY DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 355. TURKEY DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 356. ISRAEL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 357. ISRAEL DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 358. ISRAEL DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 359. ISRAEL DRUG DELIVERY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 360. ISRAEL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 361. ISRAEL DRUG DELIVERY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 362. ISRAEL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 363. ISRAEL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 364. ISRAEL DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2018-2030 (USD MILLION)
TABLE 365. ISRAEL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 366. ISRAEL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 367. ISRAEL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 368. NORWAY DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 369. NORWAY DRUG DELIVERY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 370. NORWAY DRUG DELIVERY MARKET SIZE, BY INJECTABLE, 2018-2030 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Delivery market report include:
  • Johnson & Johnson
  • Becton Dickinson and Company
  • Baxter International Inc.
  • Medtronic plc
  • 3M Company
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Fresenius Kabi AG
  • Sanofi S.A.

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.66 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Novel Drug Delivery Systems Market by Route of Administration, Technology, Application, Product Type, End User - Global Forecast to 2030 - Product Image

Novel Drug Delivery Systems Market by Route of Administration, Technology, Application, Product Type, End User - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Drug & Gene Delivery Devices Market by Technology, Delivery Mode, Device Type, Molecule Type, Therapeutic Area, End User, Application - Global Forecast to 2030 - Product Image

Drug & Gene Delivery Devices Market by Technology, Delivery Mode, Device Type, Molecule Type, Therapeutic Area, End User, Application - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029 - Product Image

Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029

  • Report
  • 719 Pages
  • Global
From
Electronic Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Implantable Drug Delivery Devices, Smart Metered Dose Inhalers), Application (Diabetes, Oncology), Region, with Growth Forecasts, 2025-2030 - Product Image

Electronic Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Implantable Drug Delivery Devices, Smart Metered Dose Inhalers), Application (Diabetes, Oncology), Region, with Growth Forecasts, 2025-2030

  • Report
  • 140 Pages
  • Global
From

About the Market

The Drug Delivery market is a sector of the pharmaceutical industry that focuses on the development and manufacture of drug delivery systems. These systems are designed to deliver drugs to the body in a safe and effective manner. Drug delivery systems can include oral, topical, injectable, and inhalable forms. They can also include transdermal patches, implants, and other devices. Drug delivery systems are designed to improve the efficacy of drugs, reduce side effects, and improve patient compliance. They can also be used to target specific areas of the body, such as the lungs or the brain. Some of the leading companies in the Drug Delivery market include Pfizer, Novartis, Merck, and Johnson & Johnson. Other companies include Sanofi, GlaxoSmithKline, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.